Details of Drug-Metabolizing Enzyme (DME)
| General Information of DME (ID: DME1548) | |||||
|---|---|---|---|---|---|
| DME Name | Unclear metabolic mechanism (DME-unclear), Eubacterium coprostanoligenes | ||||
| Gene Name | DME-unclear | ||||
| Lineage | Species: Eubacterium coprostanoligenes (Click to Show/Hide the Complete Species Lineage) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME | |||||
| Tissue Distribution | Primarily distributed in human gut. | ||||
| Full List of Drug(s) Metabolized by This DME | |||||
|---|---|---|---|---|---|
| Drugs in Phase 2 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
ANW-32821 |
Drug Info | Phase 2 | Cone rod dystrophy | ICD11: 9B70 | [1] |
| References | |||||
|---|---|---|---|---|---|
| 1 | Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222. Steroids. 1996 Jan;61(1):33-40. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.